| Literature DB >> 35949965 |
Mahir Topaloğlu1, Ayşegül Ketenci2, Barış Baslo3, Türker Şahinkaya4.
Abstract
Objectives: This study aims to understand the effectiveness of whole-body vibration (WBV) exercises performed with home exercise program in patients with post-polio syndrome (PPS) in terms of muscle strength, fatigue, the quality of life, and laboratory parameters. Patients and methods: Between October 2015 and March 2016, a total of 14 patients (7 males, 7 females; mean age: 45.1±6.6 years; range, 34 to 57 years) who were diagnosed with PPS were included in the study. The patients were randomized into two groups: the first group received WBV, home exercise program and patient education while the second (control) group received home exercise program and patient education. The patients were evaluated by knee isometric and isokinetic peak torque, Fatigue Severity Scale (FSS), Fatigue Impact Scale (FIS), Nottingham Health Profile (NHP), serum creatine kinase, aspartate aminotransferase, and alanine aminotransferase at baseline and at the end of the treatment.Entities:
Keywords: Exercise; muscle strength; poliomyelitis; post-polio syndrome; whole-body vibration
Year: 2022 PMID: 35949965 PMCID: PMC9305639 DOI: 10.5606/tftrd.2022.7063
Source DB: PubMed Journal: Turk J Phys Med Rehabil ISSN: 2587-1250
Distribution of post-treatment change in scale scores in WBV group
| WBV group | Test statistics | ||||||
| Pre-treatment | Post-treatment | ||||||
| Median | IQR 25 | IQR 75 | Median | IQR 25 | IQR 75 | ||
| FSS | 48.00 | 42.00 | 58.00 | 35.00 | 29.00 | 46.00 | 0.063 |
| FIS-cognitive | 8.00 | 1.00 | 18.00 | 6.00 | 0.00 | 9.00 | 0.207 |
| FIS-physical | 13.00 | 8.00 | 30.00 | 10.00 | 7.00 | 21.00 | 0.138 |
| FIS-psychosocial | 24.00 | 7.00 | 41.00 | 6.00 | 3.00 | 27.00 | 0.028 |
| FIS-total | 45.00 | 14.00 | 89.00 | 23.00 | 11.00 | 54.00 | 0.028 |
| NHP-pain | 50.00 | 25.00 | 75.00 | 37.50 | 12.50 | 62.50 | 0.414 |
| NHP-physical | 25.00 | 25.00 | 37.50 | 37.50 | 12.50 | 37.50 | 0.705 |
| NHP-fatigue | 33.33 | 0.00 | 66.67 | 0.00 | 0.00 | 66.67 | 0.317 |
| NHP-sleep | 20.00 | 20.00 | 40.00 | 20.00 | 20.00 | 40.00 | 0.317 |
| NHP-social | 0.00 | 0.00 | 20.00 | 0.00 | 0.00 | 40.00 | 0.317 |
| NHP-emotional | 0.00 | 0.00 | 55.56 | 0.00 | 0.00 | 11.11 | 0.066 |
| WBV: Whole-body vibration; IQR: Interquartile range; FSS: Fatigue severity scale; FIS: Fatigue impact scale; NHP: Nottingham health profile; Wilcoxon test was used in dependent groups. | |||||||
Distribution of post-treatment change in scale scores in control group
| Control group | Test statistics | ||||||
| Pre-treatment | Post-treatment | ||||||
| Median | IQR 25 | IQR 75 | Median | IQR 25 | IQR 75 | ||
| FSS | 55.00 | 46.00 | 59.00 | 40.00 | 35.00 | 59.00 | 0.735 |
| FIS-cognitive | 18.00 | 2.00 | 24.00 | 18.00 | 4.00 | 28.00 | 0.071 |
| FIS-physical | 24.00 | 13.00 | 33.00 | 29.00 | 8.00 | 35.00 | 1.000 |
| FIS-psychosocial | 44.00 | 8.00 | 61.00 | 50.00 | 12.00 | 64.00 | 0.270 |
| FIS-total | 86.00 | 23.00 | 119.00 | 103.00 | 20.00 | 130.00 | 0.233 |
| NHP-pain | 62.50 | 25.00 | 62.50 | 50.00 | 0.00 | 75.00 | 0.480 |
| NHP-physical | 37.50 | 25.00 | 75.00 | 37.50 | 25.00 | 62.50 | 0.257 |
| NHP-fatigue | 33.33 | .00 | 66.67 | 33.33 | 0.00 | 66.67 | 0.317 |
| NHP-sleep | 20.00 | 20.00 | 40.00 | 20.00 | 20.00 | 40.00 | 1.000 |
| NHP-social | 0.00 | 0.00 | 60.00 | 0.00 | 0.00 | 60.00 | 1.000 |
| NHP-emotional | 11.11 | .00 | 55.56 | 0.00 | 0.00 | 55.56 | 0.577 |
| IQR: Interquartile range; FSS: Fatigue severity scale; FIS: Fatigue impact scale; NHP: Nottingham health profile; Wilcoxon test was used in dependent groups. | |||||||
Comparison of post-treatment changes in scale scores in study groups
| Control group | |||||||
| Control | WBV | Test statistics | |||||
| Median | IQR 25 | IQR 75 | Median | IQR 25 | IQR 75 | ||
| FSS | 2.00 | -20.00 | 9.00 | -10.00 | -23.00 | -2.00 | 0.456 |
| FIS-cognitive | 2.00 | 0.00 | 4.00 | -1.00 | -13.00 | 1.00 | |
| FIS-physical | 0.00 | -4.00 | 3.00 | -1.00 | -10.00 | 0.00 | 0.128 |
| FIS-psychosocial | 4.00 | -1.00 | 8.00 | -10.00 | -37.00 | -4.00 | |
| FIS-total | 3.00 | -3.00 | 18.00 | -7.00 | -60.00 | -3.00 | 0.011 |
| NHP-pain | 0.00 | -12.50 | 12.50 | 0.00 | -12.50 | 0.00 | 1.000 |
| NHP-physical | 0.00 | -12.50 | 0.00 | .00 | -12.50 | 12.50 | 0.620 |
| NHP-fatigue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.456 |
| NHP-sleep | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.710 |
| NHP-social | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.710 |
| NHP-emotional | 0.00 | -11.11 | 0.00 | -11.11 | -22.22 | 0.00 | 0.456 |
| IQR: Interquartile range; FSS: Fatigue severity scale; FIS: Fatigue impact scale; NHP: Nottingham health profile; Wilcoxon test was used in dependent groups. | |||||||
Distribution of post-treatment change in muscle strength in WBV group
| WBV group | |||||||
| Pre-treatment | Post-treatment | ||||||
| Median | IQR 25 | IQR 75 | Median | IQR 25 | IQR 75 | ||
| IKEPT-Healthy (607s, Nm) | 71.00 | 52.00 | 193.00 | 95.00 | 76.00 | 201.00 | 0.063 |
| IKEPT-Sequela (60°/s, Nm) | 12.00 | 9.00 | 38.00 | 18.00 | 12.00 | 68.00 | 0.310 |
| IKFPT-Healthy (607s, Nm) | 43.00 | 34.00 | 96.00 | 54.00 | 50.00 | 118.00 | |
| IKFPT-Sequela (607s, Nm) | 24.00 | 12.00 | 31.00 | 30.00 | 12.00 | 49.00 | 0.108 |
| IMEPT-Healthy (MVC, Nm) | 96.00 | 77.00 | 170.00 | 119.00 | 84.00 | 179.00 | 0.108 |
| IMEPT-Sequela (MVC, Nm) | 22.00 | 12.00 | 60.00 | 23.00 | 20.00 | 83.00 | |
| WBV: Whole-body vibration; IQR: Interquartile range; IKEPT: Isokinetic Extension Peak Torque; Nm: Newton-meter; IKFPT: Isokinetic Flexion Peak Torque; IMEPT: Isometric Extension Peak Torque; MVC: Maximal voluntary contraction; Wilcoxon test was used in dependent groups. | |||||||
Distribution of post-treatment change in muscle strength in control group
| Control | |||||||
| Pre-treatment | Post-treatment | Test statistics | |||||
| Median | IQR 25 | IQR 75 | Median | IQR 25 | IQR 75 | ||
| IKEPT-Healthy (607s, Nm) | 46.00 | 20.00 | 114.00 | 80.00 | 27.00 | 104.00 | 0.398 |
| IKEPT-Sequela (607s, Nm) | 12.00 | 7.00 | 14.00 | 23.00 | 12.00 | 24.00 | 0.018 |
| IKFPT-Healthy (607s, Nm) | 43.00 | 38.00 | 77.00 | 53.00 | 37.00 | 75.00 | 0.233 |
| IKFPT-Sequela (607s, Nm) | 14.00 | 5.00 | 18.00 | 22.00 | 9.00 | 37.00 | 0.027 |
| IMEPT-Healthy (MVC, Nm) | 73.00 | 23.00 | 111.00 | 111.00 | 28.00 | 149.00 | 0.018 |
| IMEPT-Sequela (MVC, Nm) | 18.00 | 16.00 | 26.00 | 27.00 | 22.00 | 41.00 | 0.018 |
| IQR: Interquartile range; IKEPT: Isokinetic Extension Peak Torque; Nm: Newton-meter; IKFPT: Isokinetic Flexion Peak Torque; IMEPT: Isometric Extension Peak Torque; MVC: Maximal voluntary contraction; Wilcoxon test was used in dependent groups. | |||||||